RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Gyre Therapeutics Net Income 2024

Gyre Therapeutics Net Income

-39.23 M USD

Gyre Therapeutics Dividend yield

30.03 %

Ticker

GYRE

ISIN

US4037831033

WKN

A3EE5F

In 2024, Gyre Therapeutics's profit amounted to -39.23 M USD, a -57.79% increase from the -92.93 M USD profit recorded in the previous year.

The Gyre Therapeutics Net Income history

YEARNET INCOME (undefined USD)
2025e-26.15
2024e-39.23
2023-92.93
2022-8.24
2021-87.93
2020-56.24
2019-55.18
2018-30.06
2017-25.51
2016-16.95
2015-14.76
2014-6.61
2013-9.97
2012-7
2011-8.53
201010.9
2009-39.4
2008-25.66
2007-28.07
2006-1.24
2005-40.23
2004-43.08

Gyre Therapeutics Aktienanalyse

What does Gyre Therapeutics do?

Gyre Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Gyre Therapeutics's Profit Margins

The profit margins of Gyre Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Gyre Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Gyre Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Gyre Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Gyre Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Gyre Therapeutics Stock

How much profit has Gyre Therapeutics made this year?

Gyre Therapeutics has made -39.23 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -57.79% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Gyre Therapeutics publish its earnings?

Gyre Therapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Gyre Therapeutics?

The profits of Gyre Therapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Gyre Therapeutics?

You can learn more about the earnings of Gyre Therapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Gyre Therapeutics pay?

Over the past 12 months, Gyre Therapeutics paid a dividend of 3.6 USD . This corresponds to a dividend yield of about 30.03 %. For the coming 12 months, Gyre Therapeutics is expected to pay a dividend of 3.6 USD.

What is the dividend yield of Gyre Therapeutics?

The current dividend yield of Gyre Therapeutics is 30.03 %.

When does Gyre Therapeutics pay dividends?

Gyre Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gyre Therapeutics?

Gyre Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Gyre Therapeutics?

For the upcoming 12 months, dividends amounting to 3.6 USD are expected. This corresponds to a dividend yield of 30.03 %.

In which sector is Gyre Therapeutics located?

Gyre Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gyre Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gyre Therapeutics from 1/12/2023 amounting to 0.24 USD, you needed to have the stock in your portfolio before the ex-date on 1/13/2023.

When did Gyre Therapeutics pay the last dividend?

The last dividend was paid out on 1/12/2023.

What was the dividend of Gyre Therapeutics in the year 2023?

In the year 2023, Gyre Therapeutics distributed 21.45 USD as dividends.

In which currency does Gyre Therapeutics pay out the dividend?

The dividends of Gyre Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gyre Therapeutics

Our stock analysis for Gyre Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gyre Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.